Request an Appointment

If this is a medical emergency, please dial 9-1-1. This form should not be used in an emergency.

Patient Information
Date of Birth:
Contact Information
Appointment Details
Send RequestIf you do not see the specialty you are looking for, please call us at: 617-355-6000.International visitors should call International Health Services at +1-617-355-5209.
Please complete all required fields

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

This department is currently not accepting appointment requests online. Please call us at: 617-355-6000. International +1-617-355-6000.

Thank you.

Your request has been successfully submitted

You will be contacted within 1 business day.

If you have questions or would like more information, please call:

617-355-6000 +1-617-355-6000
Find a Doctor
Search by Clinician's Last Name or Specialty:
Select by Location:
Search by First Letter of Clinician's Last Name: *ABCDEFGHIJKLMNOPQRSTUVWXYZ
Condition & Treatments
Search for a Condition or Treatment:
View allSearch

Contact Us

Brain Center BCH MIT Enterprise

LIke ThisLIke ThisLIke ThisLIke ThisLIke This

The CHB-MIT Enterprise fosters the collaboration of investigators from Boston Children’s Hospital and the Massachusetts Institute of Technology in their common pursuit of groundbreaking basic and translational research.

Our goal is to advance understanding and innovation in the biosciences through the “chemical reaction” triggered by the combination of diverse perspectives.

The Enterprise is working toward this goal through a major initiative:

  • joint research grants

The ultimate research grant: Boston Children’s and MIT

With collaboration in mind, Boston Children’s and MIT are forging closer links: the BCH & MIT grant. These are one-year grants to support research between the two institutions. Even the applications must be co-initiated and co-funded by two researchers, one with a primary faculty appointment at Children’s and one at MIT.


Ideally, these funds are to be used to hire a student or postdoc. There are no restrictions on nationality or other demographic characteristics. OSP review and approval is not needed prior to your application, but it will be needed prior to the award. Yet other institutional requirements (e.g., approval of the department head if necessary) must still be obtained.

Once selected, each grant is for $47,000 in direct costs, for one year, with no overhead.


Inside our application process

If you have any questions before submitting or when you’re ready to submit, send your questions or application to Applications will be accepted until August 15, 2012, and selected by peer review. Funding decisions will be announced in early October, 2012.


All applications will be judged on:

1. Intellectual merit—on both innovation and impact.

2. Collaborative nature—our goal is to link the labs. So a BCH fellow may spend a year at MIT or vice versa.

3. Synergism—using resources from both campuses.




Our universal application format

To make this process universal, we ask that all information be filled on blank NIH continuation pages. Also, we ask that you use Arial 11 or comparable fonts and combine everything on a single .pdf document. Here’s what we need:

1. Coversheet (1 page).

  • Title of proposal

  • Name and contact information of both PIs.

    • Abstract (200 words) of proposed research and 3-5 key words (e.g. “chemical biology”)

  • Statement that any proposed animal work is covered by approved protocol(s), and specification of whose lab(s) will be used.

  • Brief description of a) the relationship between the PIs, b) the way in which the work enhances collaboration between the institutions.

2. Research proposal (1 page).

3. Budget.

4. NIH-style biosketches and support pages for PIs of both labs


The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”
- Sandra L. Fenwick, President and CEO